ZARLOZ Trademark

Trademark Overview


On Friday, April 19, 2013, a trademark application was filed for ZARLOZ with the United States Patent and Trademark Office. The USPTO has given the ZARLOZ trademark a serial number of 85909248. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, November 14, 2016. This trademark is owned by Glaxo Group Limited. The ZARLOZ trademark is filed in the Pharmaceutical Products category with the following description:

(Based on Intent to Use) Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines(Based on 44(e)) Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, meta...
zarloz

General Information


Serial Number85909248
Word MarkZARLOZ
Filing DateFriday, April 19, 2013
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, November 14, 2016
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 13, 2013

Trademark Statements


Goods and Services(Based on Intent to Use) Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines(Based on 44(e)) Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
Translation of Words in MarkThe wording "ZARLOZ" has no meaning in a foreign language.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, April 26, 2013
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBrentford, Middlesex TW89GS
GB

Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBrentford, Middlesex TW89GS
GB

Trademark Events


Event DateEvent Description
Monday, November 14, 2016ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, November 14, 2016ABANDONMENT - NO USE STATEMENT FILED
Thursday, March 24, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, March 23, 2016EXTENSION 5 GRANTED
Thursday, March 3, 2016EXTENSION 5 FILED
Thursday, March 3, 2016TEAS EXTENSION RECEIVED
Friday, September 11, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, September 10, 2015EXTENSION 4 GRANTED
Tuesday, September 8, 2015EXTENSION 4 FILED
Tuesday, September 8, 2015TEAS EXTENSION RECEIVED
Tuesday, June 23, 2015TEAS CHANGE OF CORRESPONDENCE RECEIVED
Saturday, April 4, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, April 3, 2015EXTENSION 3 GRANTED
Friday, March 27, 2015EXTENSION 3 FILED
Friday, March 27, 2015TEAS EXTENSION RECEIVED
Friday, October 17, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, October 16, 2014EXTENSION 2 GRANTED
Tuesday, September 30, 2014EXTENSION 2 FILED
Tuesday, October 14, 2014CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, September 30, 2014TEAS EXTENSION RECEIVED
Wednesday, March 26, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, March 24, 2014EXTENSION 1 GRANTED
Monday, March 24, 2014EXTENSION 1 FILED
Monday, March 24, 2014TEAS EXTENSION RECEIVED
Tuesday, October 8, 2013NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, August 13, 2013OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 13, 2013PUBLISHED FOR OPPOSITION
Wednesday, July 24, 2013NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, July 9, 2013APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, July 8, 2013ASSIGNED TO EXAMINER
Friday, April 26, 2013NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, April 23, 2013NEW APPLICATION ENTERED IN TRAM